The Radiological Society of North America has awarded the RSNA Travel Award for a work of the Section of Muscle-Skeletal Radiology at Vall d'Hebron based on the possibility of anticipating, through diagnostic imaging techniques, which neurofibromas can start to become malignant and develop borderline neurofibromas or malignant peripheral nerve sheath tumours (MPNST) of low grade. The project, led by Dr. Rosa Domínguez Oronoz from the research group on %20http:/www.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186896 Magnetic Resonance and Neuroradiology at the Vall d'Hebron Research Institute (VHIR), with the help of Dr. Cleofe Romagosa from the Department of Pathological Anatomy and Dr. Marc Simón Perdigón of the Nuclear Medicine Department, has been possible thanks to the multidisciplinary approach due to the importance of PET-CT and the analysis of pathological anatomy in these tumours. It should be noted that the work has been published by the magazine http://www.auntminnie.com/index.aspx?sec=rca&sub=rsna_2017&pag=dis&ItemID=119141 Auntminnie, a leading American journal in the field of Radiology, and has interviewed one of the authors of the project and fourth-year resident at the Vall d'Hebron Hospital, Joan Albert Prat Matifoll, who describes "according to our point of view, the combination between magnetic resonance and PET-CT is essential to diagnose, determine the extent and monitor the evolution towards more malignant forms of multiple neurofibromas in these patients". Now we just have to get more patients and continue to monitor the patients already included in the research, to describe in more detail which are the most sensitive and specific imaging modalities to detect malignant changes in these patients, and thus provide treatments or less aggressive surgeries in the future.